Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections

Clinical Infectious Diseases - Tập 42 Số 12 - Trang 1726-1734 - 2006
Issam Raad1, John R. Graybill2, A. B. Bustamante3, Oliver A. Cornely4, Verónica Alejandra Gaona-Flores5, Claude Afif1, Donald R. Graham6, Richard N. Greenberg7, Susan Hadley8, Amelia Langston9, Ricardo Negroni10, John R. Perfect11, Punnee Pitisuttithum12, Ángela Restrepo13, Gary J. Schiller14, Lisa D. Pedicone15, Andrew J. Ullmann16
1The University of Texas MD Anderson Cancer Center, Houston
2University of Texas Health Science Center, San Antonio
3Hospital Nacional Cayetano Heredia, Lima, Peru
4Universitaet Koeln, Koeln
5Hospital de Infectologia, Centro Médico Nacional La Raza, Mexico City, Mexico
6Springfield Clinical Research, Springfield, Illinois
7University of Kentucky Medical Center, Lexington
8New England Medical Center, Boston, Massachusetts
9Emory University Hospital, Atlanta, Georgia
10Hospital Muňiz, Buenos Aires, Argentina
11Duke University Medical Center, Durham, North Carolina
12Mahidol University, Bangkok, Thailand
13Clínica Cardiovascular Colombiana, Medellín, Colombia
14University of California—Los Angeles School of Medicine, Los Angeles
15Schering-Plough Research Institute, Kenilworth, New Jersey
16Medizinische Klinik und Poliklinik der Johannes Gutenberg-Universität Mainz, Mainz, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

2003, Blood, 102, 195

Lodge, 2004, Journal of Clinical Microbiology, 42, 1376, 10.1128/JCM.42.3.1376-1378.2004

Cacciapuoti, 2000, Antimicrobial Agents and Chemotherapy, 44, 2017, 10.1128/AAC.44.8.2017-2022.2000

2003, Clinical Infectious Diseases, 36, 1488, 10.1086/375075

2002, Clinical Infectious Diseases, 34, 1648, 10.1086/340522

Diekema, 2002, Journal of Clinical Microbiology, 40, 1298, 10.1128/JCM.40.4.1298-1302.2002

2004, Clinical Infectious Diseases, 39, 743, 10.1086/423274

2004, 101, 1594, 10.1002/cncr.20554

Keating, 2005, Drugs, 65, 1553, 10.2165/00003495-200565110-00007

Courtney, 2003, Antimicrobial Agents and Chemotherapy, 47, 2788, 10.1128/AAC.47.9.2788-2795.2003

Wexler, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 21, 645, 10.1016/j.ejps.2004.01.005

Krieter, 2004, Antimicrobial Agents and Chemotherapy, 48, 3543, 10.1128/AAC.48.9.3543-3551.2004

2004, Clinical Infectious Diseases, 38, e15, 10.1086/380840

2005, Clinical Infectious Diseases, 40, 1770, 10.1086/430303

Courtney, 2005, The Journal of Clinical Pharmacology, 45, 185, 10.1177/0091270004271402

Ullmann, 2003, Current medical research and opinion, 19, 263, 10.1185/030079903125001884

Romero, 2002, Clinical pharmacology and therapeutics, 71, 226, 10.1067/mcp.2002.121911

2003, Clinical Infectious Diseases, 36, 1089, 10.1086/374252

Winston, 2003, Annals of Internal Medicine, 138, 705, 10.1001/archinte.163.6.705

Gallin, 2003, New England Journal of Medicine, 348, 2416, 10.1056/NEJMoa021931

Herbrecht, 2002, New England Journal of Medicine, 347, 408, 10.1056/NEJMoa020191

2002, Clinical Infectious Diseases, 34, 563, 10.1086/324620

2003, Clinical Infectious Diseases, 36, 1122, 10.1086/374557

2002, Clinical Infectious Diseases, 35, 1273, 10.1086/343746

Graybill, 2001, International journal of clinical practice, 55, 633, 10.1111/j.1742-1241.2001.tb11144.x

Espinel-Ingroff, 1998, Journal of Clinical Microbiology, 36, 2950, 10.1128/JCM.36.10.2950-2956.1998

2003, Journal of Antimicrobial Chemotherapy, 51, 513, 10.1093/jac/dkg117

Arikan, 2001, Antimicrobial Agents and Chemotherapy, 45, 327, 10.1128/AAC.45.1.327-330.2001

Del Poeta, 1997, Antimicrobial Agents and Chemotherapy, 41, 1835, 10.1128/AAC.41.8.1835

Pfaller, 1998, Diagnostic microbiology and infectious disease, 30, 251, 10.1016/S0732-8893(97)00246-0

2006, Clinical Infectious Diseases, 42, 1179, 10.1086/501457